 the costs of the different treatment options and
counsel their patients accordingly.
Because cost-effectiveness will vary with the setting
and local reimbursement system, and most data on
cost have come from outside the United States, our supporting systematic review did not evaluate costeffectiveness. In British studies, physician-compounded
UGFS had had the lowest initial costs, although this
was partially offset by the long-term costs of reintervention and lower QoL.85,156 High l